“There are all kinds of things you need to do to bring a food ingredient to market and Motif will be able to focus on that, as well as manufacturing ingredients and working with its suppliers on new ingredients. Ginkgo has spun off its food business into a start-up called Motif Ingredients, which has raised $90m in series A funding to develop alternative protein products for the plant-based and meat-free industry. The company is also working on an edible version of the drug that could be used as a painkiller or anti-inflammatory. Investors in the funding round included Breakthrough Energy Ventures, Louis Dreyfus, Fonterra and Viking Global Investors.
Ginkgo has spun off its food business into a start-up called Motif Ingredients, which has raised $90m in series A funding to develop alternative protein products for the plant-based and meat-free industry. The company is also working on an edible version of the drug that could be used as a painkiller or anti-inflammatory. Investors in the funding round included Breakthrough Energy Ventures, Louis Dreyfus, Fonterra and Viking Global Investors.